 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis
2 October 2001 | Volume 135 Issue 7 | Page S45
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine.
The summary below is from the full report titled "Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis." It is in the 2 October 2001 issue of Annals of Internal Medicine (volume 135, pages 502-506). The authors are TE Warkentin and JG Kelton.
What is the problem and what is known about it so far?
Blood thinners, such as heparin, are often needed to treat patients who have developed (or are at risk for) blood clots in their veins or arteries. It has been known for many years that a small proportion of these patients has an adverse reaction to heparin administration characterized by a decrease in the number of platelets (particles that are necessary for blood clot formation) circulating in the blood. This abnormality is known as heparin-induced thrombocytopenia. The reaction is caused by development of antibodies (proteins made by the immune system of the body) against a combination of platelets and heparin, which destroy the platelets. A common but unexpected feature of heparin-induced thrombocytopenia is the formation of new blood clots that are often life-threatening. Usually, heparin-induced thrombocytopenia occurs 5 or more days after the start of heparin therapy, and while the patient is receiving the drug.
Why did the researchers do this particular study?
The researchers wanted to describe the syndrome of delayed-onset heparin-induced thrombocytopenia, in which thrombocytopenia begins 5 or more days after heparin therapy is stopped.
Who was studied?
12 patients who developed heparin-induced thrombocytopenia at least 5 days after heparin treatment was stopped.
How was the study done?
The researchers performed two tests on the blood of each of the 12 patients to detect the presence of antibodies against the combination of heparin and platelets. They then compared the results with those from typical patients with heparin-induced thrombocytopenia whose platelet counts decreased while they were receiving the drug.
What did the researchers find?
Thrombocytopenia and blood clot formation began an average of 9 days after the last dose of heparin. Six of the patients had been discharged from the hospital before the platelet count decreased. All 12 patients developed blood clots; most clots were in the veins, but some patients had clots in arteries as well. Nine of the 12 patients were not recognized as having delayed-onset heparin-induced thrombocytopenia and received additional heparin to treat the blood clot formation. All of these patients had a further decrease in platelets, and 1 had a cardiac arrest 15 minutes after receiving the additional heparin.
What were the limitations of the study?
A relatively small number of patients with this disorder has been described.
What are the implications of the study?
Physicians need to consider the diagnosis of delayed-onset heparin-induced thrombocytopenia when patients who have recently received heparin present with new blood clot formation and decreased numbers of platelets, even when the drug has not been given for many days. Such patients should not be given additional heparin.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  T. E. Warkentin, A. Greinacher, A. Koster, and A. M. Lincoff Treatment and Prevention of Heparin-Induced Thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 340S - 380S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Jackson Everett BM, et al. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery. Ann Thorac Surg. 2007;83:592-597 Perspectives in Vascular Surgery and Endovascular Therapy, March 1, 2008; 20(1): 102 - 103. [Abstract] [PDF]
|
|
|
|
 |
|
 J. H. Levy, K. A. Tanaka, and M. J. Hursting Reducing Thrombotic Complications in the Perioperative Setting: An Update on Heparin-Induced Thrombocytopenia Anesth. Analg., September 1, 2007; 105(3): 570 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I Ahmed, A Majeed, and R Powell Heparin induced thrombocytopenia: diagnosis and management update Postgrad. Med. J., September 1, 2007; 83(983): 575 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J. Am. Coll. Cardiol., August 14, 2007; 50(7): e1 - e157. [Full Text] [PDF]
|
|
|
|
|
|
T. E. Warkentin and J. W. Eikelboom Who Is (Still) Getting HIT? Chest, June 1, 2007; 131(6): 1620 - 1622. [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Cooney Heparin-induced thrombocytopenia: advances in diagnosis and treatment. Crit. Care Nurse, December 1, 2006; 26(6): 30 - 36. [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Warkentin, J.-A. I. Sheppard, C. S. Sigouin, T. Kohlmann, P. Eichler, and A. Greinacher Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia Blood, November 1, 2006; 108(9): 2937 - 2941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Levine, D. McCollum, and M. J. Hursting How frequently is venous thromboembolism in heparin-treated patients associated with heparin-induced thrombocytopenia? Chest, September 1, 2006; 130(3): 681 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Arepally and T. L. Ortel Heparin-Induced Thrombocytopenia N. Engl. J. Med., August 24, 2006; 355(8): 809 - 817. [Full Text] [PDF]
|
|
|
|
|
|
T. E. Warkentin HIT without (more) heparin Blood, March 15, 2006; 107(6): 2214 - 2215. [Full Text] [PDF]
|
|
|
|
|
|
L. Rauova, L. Zhai, M. A. Kowalska, G. M. Arepally, D. B. Cines, and M. Poncz Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications Blood, March 15, 2006; 107(6): 2346 - 2353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Anticoagulation for cardiopulmonary bypass: is a replacement for heparin on the horizon? J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 515 - 516.
|
|
|
|
 |
|
 A. K. Lilikakis, T. Papapolychroniou, G. Macheras, and E. Michelinakis Thrombocytopenia and Intra-cerebral Complications Associated with Low-Molecular-Weight Heparin Treatment in Patients Undergoing Total Hip Replacement. A Report of Two Cases J. Bone Joint Surg. Am., March 1, 2006; 88(3): 634 - 638. [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Jackson, W. J. Neilson, M. Lary, P. Baay, K. Web, and G. P. Clagett Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis After Intraoperative Heparin Anticoagulation: Four Case Reports Vascular and Endovascular Surgery, January 1, 2006; 40(1): 67 - 70. [Abstract] [PDF]
|
|
|
|
 |
|
 T. E. Warkentin Think of HIT Hematology, January 1, 2006; 2006(1): 408 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Prandoni, S. Siragusa, B. Girolami, F. Fabris, and for the BELZONI Investigators Group The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study Blood, November 1, 2005; 106(9): 3049 - 3054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I.-K. Jang and M. J. Hursting When Heparins Promote Thrombosis: Review of Heparin-Induced Thrombocytopenia Circulation, May 24, 2005; 111(20): 2671 - 2683. [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Sanfelippo Heparin-Induced Thrombocytopenia--A Potential Iatrogenic Complication for Patients with Cardiac and Vascular Disease Angiology, May 1, 2005; 56(3): 305 - 309. [Abstract] [PDF]
|
|
|
|
|
|
R. L. Levine Finding Haystacks Full of Needles: From Opus to Osler Chest, May 1, 2005; 127(5): 1488 - 1490. [Full Text] [PDF]
|
|
|
|
|
|
L. Rice Cases of Heparin-Induced Thrombocytopenia Elucidate the Syndrome Chest, February 1, 2005; 127(2_suppl): 21S - 26S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Bartholomew Transition to an Oral Anticoagulant in Patients With Heparin-Induced Thrombocytopenia Chest, February 1, 2005; 127(2_suppl): 27S - 34S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Warkentin New Approaches to the Diagnosis of Heparin-Induced Thrombocytopenia Chest, February 1, 2005; 127(2_suppl): 35S - 45S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Warkentin Heparin-Induced Thrombocytopenia: Diagnosis and Management Circulation, November 2, 2004; 110(18): e454 - e458. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Rice Heparin-Induced Thrombocytopenia: Myths and Misconceptions (That Will Cause Trouble for You and Your Patient) Arch Intern Med, October 11, 2004; 164(18): 1961 - 1964. [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Smythe, W. E. Dager, and N. M. Patel Managing Complications of Anticoagulant Therapy Journal of Pharmacy Practice, October 1, 2004; 17(5): 327 - 346. [Abstract] [PDF]
|
|
|
|
|
|
T. E. Warkentin and A. Greinacher Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 311S - 337S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Mosen, C. G. Elliott, M. J. Egger, M. Mundorff, J. Hopkins, R. Patterson, and R. M. Gardner The Effect of a Computerized Reminder System on the Prevention of Postoperative Venous Thromboembolism Chest, May 1, 2004; 125(5): 1635 - 1641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kannan, R. Ahmed, S. Kale, S. Ahmad, J. Fareed, and R. Saxena Laboratory Diagnosis of Heparin-Induced Thrombocytopenia in Asian Indians as Investigated With Functional and Immunologic Methods Clinical and Applied Thrombosis/Hemostasis, January 1, 2004; 10(1): 51 - 54. [Abstract] [PDF]
|
|
|
|
 |
|
 T. E. Warkentin and A. Greinacher Heparin-induced thrombocytopenia and cardiac surgery Ann. Thorac. Surg., December 1, 2003; 76(6): 2121 - 2131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Warkentin and A. Greinacher Heparin-induced thrombocytopenia and cardiac surgery Ann. Thorac. Surg., August 1, 2003; 76(2): 638 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Girolami, P. Prandoni, P. M. Stefani, C. Tanduo, P. Sabbion, P. Eichler, R. Ramon, G. Baggio, F. Fabris, and A. Girolami The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study Blood, April 15, 2003; 101(8): 2955 - 2959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Warkentin and R. A. Bernstein Delayed-Onset Heparin-Induced Thrombocytopenia and Cerebral Thrombosis after a Single Administration of Unfractionated Heparin N. Engl. J. Med., March 13, 2003; 348(11): 1067 - 1069. [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Shah and J. P. Spencer Heparin-Induced Thrombocytopenia Occurring After Discontinuation of Heparin J Am Board Fam Med, March 1, 2003; 16(2): 148 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Warkentin Pork or beef? Ann. Thorac. Surg., January 1, 2003; 75(1): 15 - 16. [Full Text] [PDF]
|
|
|
|
|
|
J. L. Francis, G. J. Palmer III, R. Moroose, and A. Drexler Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery Ann. Thorac. Surg., January 1, 2003; 75(1): 17 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Warkentin, W. C. Aird, and J. H. Rand Platelet-Endothelial Interactions: Sepsis, HIT, and Antiphospholipid Syndrome Hematology, January 1, 2003; 2003(1): 497 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Alving How I treat heparin-induced thrombocytopenia and thrombosis Blood, January 1, 2003; 101(1): 31 - 37. [Full Text] [PDF]
|
|
|
|
 |
|
 T. G. DeLoughery Thrombocytopenia in Critical Care Patients J Intensive Care Med, November 1, 2002; 17(6): 267 - 282. [Abstract] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
